EUnetHTA JA2 delivers an upgraded universal HTA Core Model for flexible application across health technologies. The updated HTA Core Model Licence and Guiding Principles on Use clarify conditions for its use by anyone
We are happy to announce that the final guideline on "Therapeutic medical devices" is now available.
We are pleased to announce that the Joint "Rapid relative effectiveness assessment of new pharmaceuticals for the treatment of chronic Hepatitis C" og WP5-SA6 is now available.
We are pleased to announce that the 6th pilot rapid assessment of WP5 JA2 Strand B on “Endovascular therapy using mechanical thrombectomy devices for acute ischaemic stroke” is available.
We are happy to announce that the third Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback. The topic assessed is “Structured telephone support (STS) for adult patients with chronic heart failure”